SecSonar.com

Embecta Corp. (EMBC)

Embecta Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Embecta Corp. (EMBC) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $192.5M. Revenue declined 3.8% year-over-year and the company generated $182.4M in free cash flow. This page tracks EMBC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2K employees · IPO Mar 22, 2022

Valuation

Valuation & price

$3.14 · as of May 17, 2026 · -79.5% vs 52w high

1.9

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$15.31$9.11$2.90Jul 25Dec 25Jun 26Jul 7, 25$10.03Jul 9, 25$10.60Jul 11, 25$10.47Jul 15, 25$9.58Jul 17, 25$9.85Jul 21, 25$10.29Jul 23, 25$11.63Jul 25, 25$11.73Jul 29, 25$10.75Jul 31, 25$10.16Aug 4, 25$9.79Aug 6, 25$9.87Aug 8, 25$12.28Aug 12, 25$13.32Aug 14, 25$13.87Aug 19, 25$13.64Aug 21, 25$13.83Aug 25, 25$14.26Aug 27, 25$14.59Aug 29, 25$14.48Sep 3, 25$14.31Sep 5, 25$14.96Sep 9, 25$15.23Sep 11, 25$15.31Sep 15, 25$15.08Sep 17, 25$15.06Sep 19, 25$14.34Sep 23, 25$14.57Sep 25, 25$13.69Sep 29, 25$14.00Oct 2, 25$14.26Oct 6, 25$14.19Oct 8, 25$13.82Oct 10, 25$13.38Oct 14, 25$13.53Oct 16, 25$13.69Oct 20, 25$14.10Oct 22, 25$14.25Oct 24, 25$14.33Oct 28, 25$14.02Oct 30, 25$13.66Nov 3, 25$13.42Nov 5, 25$13.86Nov 7, 25$13.79Nov 11, 25$14.22Nov 14, 25$14.55Nov 18, 25$14.21Nov 20, 25$13.73Nov 24, 25$14.64Nov 26, 25$12.57Dec 1, 25$12.25Dec 3, 25$11.95Dec 5, 25$11.69Dec 9, 25$11.11Dec 11, 25$11.95Dec 15, 25$11.93Dec 17, 25$11.78Dec 19, 25$11.75Dec 23, 25$11.92Dec 26, 25$12.01Dec 31, 25$11.88Jan 5, 26$11.62Jan 7, 26$12.50Jan 9, 26$12.76Jan 13, 26$12.66Jan 15, 26$12.60Jan 20, 26$12.29Jan 22, 26$12.08Jan 26, 26$10.74Jan 28, 26$10.20Jan 30, 26$10.61Feb 3, 26$10.91Feb 5, 26$10.47Feb 9, 26$10.30Feb 11, 26$10.06Feb 17, 26$10.27Feb 19, 26$10.53Feb 23, 26$10.57Feb 25, 26$10.32Feb 27, 26$10.26Mar 3, 26$9.71Mar 5, 26$9.44Mar 9, 26$9.23Mar 11, 26$9.00Mar 13, 26$8.79Mar 17, 26$8.91Mar 19, 26$9.12Mar 23, 26$9.03Mar 25, 26$9.00Mar 27, 26$8.57Apr 1, 26$8.79Apr 6, 26$8.93Apr 8, 26$8.88Apr 10, 26$8.85Apr 14, 26$9.46Apr 16, 26$9.51Apr 20, 26$9.60Apr 22, 26$9.21Apr 24, 26$9.22Apr 28, 26$9.03Apr 30, 26$9.15May 4, 26$9.25May 6, 26$3.56May 8, 26$3.64May 12, 26$3.41May 15, 26$3.14May 19, 26$2.90May 21, 26$3.32May 26, 26$3.32May 28, 26$3.33Jun 1, 26$3.29Jun 3, 26$3.32Jun 5, 26$3.38Jun 9, 26$3.31Jun 11, 26$3.08Jun 15, 26$3.13Jun 17, 26$3.09Jun 22, 26$3.03Jun 24, 26$3.10Jun 30, 26$3.24
$2.9052-week range$15.31
Loading valuation history…

Fundamentals

Key fundamentals

$192.5M

Market cap

-3.8%

Revenue growth (YoY)

62.9%

Gross margin

$182.4M

Free cash flow (USD)

$1.2B

Net debt

-0.2%

Share dilution

3/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$1.1BFY 2020$1.1BFY 2021$1.2BFY 2022$1.1BFY 2023$1.1BFY 2024$1.1BFY 2025$1.1B
$1.1B$1.1B

Free cash flow by year

2019 → 2025

FY 2019$436.0MFY 2020$456.6MFY 2021$417.0MFY 2022$388.2MFY 2023$41.2MFY 2024$19.9MFY 2025$182.4M
$436M$182.4M

Gross margin by year

2021 → 2025

FY 202168.7%FY 202268.6%FY 202366.9%FY 202464.9%FY 202562.9%
68.7%62.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAcquisition CompletedMay 15, 2026Filing
  • 8-K eventFinancial Results and GuidanceMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing

Questions

Frequently asked questions

What is Embecta Corp.'s market cap?

Embecta Corp. (EMBC) has a market capitalization of $192.5M.

What is EMBC's P/E ratio?

EMBC trades at a price-to-earnings ratio of 1.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

Are insiders buying EMBC stock?

SEC Form 4 filings show no open-market insider buys at Embecta Corp. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

LFCR

Lifecore Biomedical, Inc.

$187.5M

ACB

Aurora Cannabis Inc.

$203.3M

DERM

Journey Medical Corporation

$171.5M

OGI

Organigram Global Inc.

$163.3M

ASRT

Assertio Holdings, Inc.

$151.4M

TKNO

Alpha Teknova, Inc.

$270.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.